Mar 06, 2024 | Genetics
Precision oncology continues to provide a significant survival benefit to cancer patients by matching biomarker therapy with targetable tumour-specific molecular aberrations. To this end, we offer an improved and more comprehensive solid tumour panel, the Oncomine™ Precision Assay.
Full Article